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Mutations Affecting Either Generation or
Survival of Cells Influence the Pool Size
of Mature B Cells
the periarteriolar lymphocyte sheath (PALS), where they
become part of the B cell±rich follicular areas (MacLen-
nan and Gray, 1986; Lortan et al., 1987). Immature B
cells in BM and spleen can be distinguished from their
mature counterparts by their short lifespan (3±4 days
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1993). Recently, we have described the specificity of aStubeweg 51
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the cell surface. This allows us to distinguish, in a simpler§Serono Pharmaceutical Research Institute
way than previously, immature from mature B cells14 Chemin des Aulx
found in bone marrow and spleen (Rolink et al., 1998).CH-1228 Plan-les-Ouates
Using this mAb in combination with BrdU-labeling kinet-Switzerland
ics, we confirmed the results published by others show-
ing that only a small proportion (10%±20%) of immature
B cells generated in the bone marrow enter the matureSummary
long-lived peripheral B cell pool. Moreover, our previous
study indicated that the major loss during the differentia-The mature B cell compartment of MHC class II±defi-
tion from immature to mature B cells occurs in the BMcient B6 I-Aa2/2 and the btk-defective CBA/N mouse
and/or in the homing from the BM to the spleen, whilestrain is 4- to 5-fold smaller than in wild-type B6 mice.
the majority, if not all, of the immature splenic B cellsThe defect in B6 I-Aa2/2 mice is intrinsic to B cells
do enter the mature compartment (Rolink et al., 1998).and due to a 4- to 5-fold reduced lifespan, which how-
Why and how only such a small proportion of imma-ever can be normalized by an I-Ead transgene, but only
ture B cells is selected from the BM is largely unknown.when expressed early during B cell development. The
The specificity of the expressed IgM molecule mightreduced number of mature B cells in the btk-defective
play a role (Gu et al., 1992). Evidence for a signalingCBA/N mouse is due to a 4- to 5-fold lower number
function through the expressed surface IgM comes from
of immature splenic B cells entering the mature com-
mice expressing only a truncated form of Iga (mb-1)
partment. The combined defects of reduced lifespan (Torres et al., 1996) who have a block in B cell develop-
and impaired generation in double mutant mice result ment. Particularly interesting is a similar defect at the
in a severe deficiency in the mature B cell pool. same stage of B cell development seen in invariant (iI)
chain±deficient mice (Shachar and Flavell, 1996), with
an even more severe block in double mutant mice lack-Introduction
ing both invariant chain and DM functions (Kenty et al.,
1998). However, it remains to be elucidated why defects
B cell development in the bone marrow (BM) can be
in invariant chain or DM chain synthesis affect B cell
divided into different stages, based on the rearrange- development. Moreover, the btk mutant mouse CBA/N
ment status of the IgH and IgL chain loci (Ehlich et al., and the btk-deficient mouse both show a major defect
1994; Ten Boekel et al., 1995) and the expression of in the transition from immature to mature B cells. This
intracellular and surface bound markers (Rolink et al., defect is even more pronounced in CBA/N/CD402/2 and
1994). The first cells during this developmental process btk2/2/CD402/2 double mutant mice (Oka et al., 1996;
expressing IgM at their surface are the immature B cells Khan et al., 1997).
(Rolink et al., 1994). Experiments by Osmond and his Here, using the novel mAb 493 in combination with
colleagues have shown that adult mice produce about BrdU labeling, we analyze MHC class II and btk mutant
2 3 107 of these immature B cells per day (Osmond, mice for their capacity to generate immature and mature
1991). Around 10%±20% of the immature B cells made B cells. Our results indicate that MHC class II mutant
in the bone marrow migrate to the spleen (Allman et al., mice as well as btk mutant mice produce similar num-
1993; Rolink et al., 1998) and enter through the terminal bers of immature B cells in the bone marrow, indistin-
branches of central arterioles, thus arriving in the mar- guishable from wild-type control animals. Likewise, the
ginal zone blood sinusoids (MacLennan and Chan, 1993) efficiency by which both types of immature B cells home
from which they then penetrate into the outer zone of to the spleen is equal in mutant mice compared to wild-
type controls. Moreover, the efficiency of immature
splenic B cells to differentiate into mature B cells in‖ To whom correspondence should be addressed (e-mail: antibody@
bii.ch). MHC class II mutant mice appears not to be affected.
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Figure 1. Defective B Cell Maturation in
I-Aa2/2 Mice
(A) B220/pB130-140 expression on bone mar-
row and spleen of adult B6, B6 I-Ab2/2, and
B6 I-Aa2/2 mice. Bone marrow and spleen
cells were labeled with mAb 493 and anti-
B220 mAb and were analyzed by flow cytom-
etry. Numbers in quadrants represent per-
centage of total gated lymphoid cells. The
absolute numbers of spleen cells were 6.6 6
1.6 3 107 (B6), 5.9 6 1.2 3 107 (B6 I-Ab2/2),
and 3.4 6 0.9 3 107 (B6 I-Aa2/2 mice).
(B) BrdU-labeled B2201 spleen cells. Adult
B6, B6 I-Ab2/2, and B6 I-Aa2/2 mice were
given BrdU for 4 days in their drinking water.
Splenic cells were analyzed for BrdU incorpo-
ration. Histograms represent BrdU labeling of
B2201 gated spleen cells. Numbers represent
percentage of BrdU-positive B2201 spleen
cells.
However, the efficiency of immature splenic B cells to al., 1993) that B cell development in B6 I-Ab2/2 is unal-
tered. In marked contrast, the B220/pB130-140 expres-differentiate into mature B cells in btk mutant mice ap-
pears to be 4- to 5-fold reduced resulting in a smaller sion in bone marrow and spleen of the B6 I-Aa2/2 mice is
abnormal. Thus, in the bone marrow of adult B6 I-Aa2/2splenic mature B cell compartment. The half-life of these
mature B cells appears unaffected. In contrast, the half- animals, the B220high pB130-1402 population, represent-
ing the recirculating mature B cells (Rolink et al., 1998),life of mature B cells in MHC class II mutant mice is
reduced 4- to 5-fold, also resulting in a smaller mature is almost absent (Figure 1A). However, B cell develop-
ment up to and including immature B cells in the boneperipheral B cell compartment compared to wild-type
mice. Moreover, the two mutations act in concert as the marrow of these mice is normal based on the number
of c-kit1 and CD251 pro- and pre-B cells (data notdouble mutant btk2/2/MHC Aa2/2 mice have a severely
reduced, almost undetectable, number of mature B cells shown). In the spleen of B6 I-Aa2/2, about 50% of the
B2201 cells coexpress pB130-140 (Figure 1A). The num-in the spleen.
ber of immature B cells in the spleen of these mice is
comparable to the number found in wild-type B6 andResults
B6 I-Ab2/2 mice, while the number of mature B cells is
4- to 5-fold lower (Table 1). Thus, B6 I-Aa2/2 mice areB6 I-Aa2/2 but Not B6 I-Ab2/2 Mice Have a Defect
in the Generation of Mature B Cells severely impaired in the generation and/or maintenance
of mature B cells. This conclusion was further supportedMAb 493 was used to analyze the immature and mature
B cell compartments in bone marrow and spleen of by analyzing the BrdU incorporation of splenic B cells
shown in Figure 1B. Thus, about 15% of the B2201MHC class II±deficient mouse strains B6 I-Ab2/2 and B6
I-Aa2/2, which lack I-Ab or I-Aa expression, respectively. spleen cells in B6 and B6 I-Ab2/2 mice are BrdU positive
after 4 days of BrdU feeding, while about 50% of theAs shown in Figure 1A, the B220/pB130-140 expression
in the bone marrow and the spleen of B6 I-Ab2/2 mice B2201 spleen cells in B6 I-Aa2/2 mice are labeled by
BrdU during the same time. Thus, based on both theis comparable to that observed in normal B6 mice. More-
over, the numbers of immature and mature splenic B staining with mAb 493 and the BrdU labeling, we con-
clude that B6 I-Aa2/2 mice export normal numbers ofcells are practically the same (Table 1). This confirms
previous findings (Cosgrove et al., 1991; Markowitz et immature B cells from the marrow that home at normal
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MHC Class II Expression Early during B CellTable 1. Absolute Numbers (3106) of Immature and Mature
Development Is Required for the FormationSplenic B Cells in Wild-type B6 versus Several Mutant Mice
of the Long-Lived Mature B Cell Compartment
Number of Number of
To determine whether the I-Aa2/2-dependent defectImmaturea Maturea
could be repaired by the expression of MHC class II,Mouse Strain B Cells (6SD) B Cells (1SD)
we crossed two different Ead transgenes (herein called
B6 8.90 6 0.65 38.90 6 2.20 EAD-107 and EAD-J) back onto B6 I-Aa2/2 mice. In both
B6 I-Ab2/2 9.00 6 1.10 32.50 6 1.90
cases, B6 I-Aa2/2 mice are capable of expressing theB6 I-Aa2/2 6.10 6 0.75 8.80 1 1.72
transgenic I-Ead in combination with the endogenousB6 I-Aa2/2 EAD-107 5.00 6 0.81 7.72 1 1.53
B6 I-Aa2/2 EAD-J 8.32 6 0.55 32.20 6 3.51 I-Ebb on their cell surface.
CD3e2/2 9.77 6 1.06 26.52 6 4.12 As shown in Figure 2, the B6 I-Aa2/2 mice comple-
CD42/2 9.30 6 0.62 24.20 6 2.20 mented with the EAD-107 transgene have a B220/
LAG-32/2 7.87 6 0.42 29.37 6 3.47 pB130-140 expression pattern in bone marrow and
CBA/N 7.1 6 1.82 7.75 6 2.57
spleen indistinguishable from that observed in the non-B6 I-Aa2/2 CBA/N 3.52 6 0.73 0.87 6 0.33
transgenic, I-Aa-defective littermates (compare Figures
a Immature B cells are defined as B2201/pB130-1401 while mature 1A and 2A). Moreover, the number of immature and
B cells are B2201/pB130-1402. Numbers represent the mean 6 SD
mature B cells in the spleens of these mice is practicallyof at least five individual mice analyzed at 10±15 weeks of age.
identical, indicating that the EAD-107 transgene cannotValues in bold represent significant differences compared to wild-
rescue the B cell defect of B6 I-Aa2/2 mice (Table 1).type control mice.
However, B6 I-Aa2/2 mice that carried the EAD-J trans-
gene show a normalized B220/pB130-140 expression in
rates to the spleen. However, they are either impaired bone marrow and spleen (Figure 2A). Also, the numbers
in the transition of immature to mature B cells within of immature and mature B cells in spleens of these mice
the spleen or have a mature B cell compartment that are comparable to those found in B6 mice (Table 1).
has a shorter half-life time than that of mature B cells Thus, the EAD-J transgene can rescue the B cell defect
from wild-type B6 animals. in B6 I-Aa2/2 mice while the EAD-107 transgene cannot.
To measure half-lives of B cells, mice were given BrdU The BrdU labeling studies summarized in Table 2 sup-
for 14 days in their drinking water. As shown in Table port this conclusion and show that the half-life of mature
2, over 90% of the immature splenic B cells and about B cells in B6 I-Aa2/2 mice is increased to that of wild-
15% of the mature splenic B cells in B6 and B6 I-Ab2/2 type B cells with the introduction of the EAD-J transgene,
mice are BrdU positive after this period of labeling. Thus, while the lifespan of mature B cells in B6 I-Aa2/2 mice
mature B cells in these two strains have a half-life of carrying the EAD-107 transgene remains decreased rel-
about 15±20 weeks. This conclusion is further supported ative to wild-type (Table 2).
by the finding that 2 weeks after withdrawal of the BrdU Since the EAD-107 transgene cannot correct the de-
only a minor fraction (2%±3%) of BrdU-positive mature velopmental defect in B6 I-Aa2/2 mice whereas the
B cells disappeared (Table 2). EAD-J transgene can, the obvious question isÐwhat is
In B6 I-Aa2/2 mice, over 90% of the immature splenic the difference between these two transgenic strains of
B cell compartment is also BrdU positive after 14 days mice? Although harboring identical Ead coding se-
of labeling. However, in marked contrast to B6 and B6 quences, the construct used to generate the EAD-107
I-Ab2/2 mice, about 50% of the mature splenic B cells transgenic mice consists of the Ead gene with only 1.4
in B6 I-Aa2/2 mice are BrdU positive after 14 days of kb of its 59-noncoding region. For the EAD-J trans-
labeling (Table 2). This, together with the finding that 2 genics, on the other hand, a 14 kb fragment was used
weeks after withdrawal of the BrdU only 25% of the containing the Ead gene flanked by approximately 9 kb
mature splenic B cells are still BrdU positive, indicates of 59-noncoding region. This suggested that the expres-
that the half-life of mature B cells in B6 I-Aa2/2 mice is sion of these two transgenes might be different. To test
reduced to about 4 weeks. Thus, the 4- to 5-fold de- this, cell surface I-E expression in bone marrow and
crease in number (Table 1) appears to be due to a de- spleen of B6 I-Aa2/2 mice harboring either the EAD-
creased lifespan from 15±20 weeks to 4 weeks of mature 107 or the EAD-J transgene was analyzed. As shown in
Figure 2B, I-E expression is hardly, if at all, detectableB cells in B6 I-Aa2/2 mice.
Table 2. Percentage of BrdU Positive Immature and Mature Splenic B Cells
After 2 Weeks Continuous Labeling
After 2 Weeks Continuous Labeling and 2 Weeks Chase
Immature Mature Immature Mature
Strain of Mice B Cellsa B Cellsa B Cellsa B Cellsa
B6 95.0 6 4.1 18.3 6 2.1 3.1 6 2.5 14.7 6 2.7
B6 I-Ab2/2 92.3 6 6.2 17.0 6 2.3 4.1 6 0.6 14.9 6 3.1
B6 I-Aa2/2 91.0 6 3.1 53.2 6 3.7 2.0 6 0.3 24.2 6 1.8
B6 I-Aa2/2 EAD-107 93.2 6 0.7 49.5 6 1.6 1.8 6 0.4 23.4 6 0.7
B6 I-Aa2/2 EAD-J 95.1 6 2.3 22.3 6 2.9 2.0 6 1.5 21.0 6 2.6
CBA/N 93.6 6 2.8 21.0 6 3.0 1.5 6 0.8 18.7 6 2.5
a Immature B cells are defined as B2201/pB130-1401 while mature B cells are B2201/pB130-1402. The percentages represent the mean 6
SD of at least three individual mice analyzed. Values in bold represent significant differences compared to wild-type control mice.
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Figure 2. Complementation of the B Cell De-
fect in I-Aa2/2 Mice by an I-Ea Transgene
(A) B220/pB130-140 expression on bone mar-
row and spleen cells of adult B6 I-Aa2/2 mice
complemented with the EAD-107 or the
EAD-J transgene. Spleen and bone marrow
cells were labeled with mAb 493 (anti-pB130-
140) and an anti-B220 mAb and were ana-
lyzed by flow cytometry.
(B) I-E expression on bone marrow and
spleen cells of B6 I-Aa2/2 mice comple-
mented with the EAD-107 or the EAD-J trans-
gene. Spleen and bone marrow cells were
labeled with the I-E-specific mAb 14-4-4S
(Pharmingen) and an anti-B220 mAb and then
analyzed by flow cytometry. Numbers in
quadrants indicate percentage of total gated
lymphoid cells. Total number of spleen cells
were 3.3 6 0.6 3 107 (EAD-107) and 6.0 6
0.7 3 107 (EAD-J).
in the bone marrow of EAD-107 transgenic mice. On the cell precursors is required for mature B cells to become
long lived.other hand, I-E is strongly expressed on the majority of
B2201 B cell precursors in EAD-J transgenic mice. In
the spleen of EAD-J transgenic mice, all B cells express The Mature B Cell Maintenance Defect in B6 I-Aa2/2
Mice Is Intrinsic to the B Cellshigh levels of the I-E transgene. In the EAD-107 mice,
only a fraction of the B cells have detectable I-E on their To test whether the mature B cell defect in B6 I-Aa2/2
mice is B cell intrinsic or due to the absence of Aasurface. Double labeling analysis with an anti-I-E mAb
and mAb 493 or anti-CD23, respectively, on spleen cells expression in or on other cells, BM chimeric mice were
made. B6 mice were lethally irradiated and injected ei-of the B6 I-Aa2/2 EAD-107 transgenic mice revealed that
the majority of the immature pB130-1401 B cells do not ther with 5 3 106 B6 Ly5.1 or with 5 3 106 B6 I-Aa2/2
(Ly5.2) or with a mixture consisting of 2.5 3 106 BM cellsexpress I-E at all, or only at very low levels, while the
majority of the mature CD231 B cells express the I-E of each. As shown in Table 3, B6 Ly5.1 chimeras have
an immature, as well as a mature, splenic B cell compart-transgene (data not shown).
We conclude from these experiments that a difference ment similar in size to wild-type B6 mice, while in the B6
I-Aa2/2 chimeras these are similar to mutant B6 I-Aa2/2in transgene expression appears to be the most likely
explanation for why the EAD-J transgene can, and the mice, i.e., with a reduced size of the mature B cell com-
partment. Thus, MHC class II expression on nonhemato-EAD-107 cannot, correct the B cell defect in B6 I-Aa2/2
mice. Moreover, these findings suggest that I-Aa or I-Ea poetic cells of the B6 host does not rescue the B cell
defect of the B6 I-Aa2/2 mouse.expression on immature or possibly even on earlier B
Regulation of the Mature B Cell Pool Size
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Table 3. Absolute Numbers (3106) of Immature and Mature Splenic B Cells in Lethally Irradiated B6 Mice Reconstituted with Bone
Marrow Cells from Various Mouse Strains
Number of Immature B Cells De- Number of Mature B Cells Derived
rived froma froma
Bone Marrow Cell Origin B6 Ly5.1 B6 I-Aa2/2 B6 Ly5.1 B6 I-Aa2/2
B6 Ly5.1 7.2 6 0.9 Ð 25.7 6 3.9 Ð
B6 I-Aa2/2 Ð 6.2 6 0.7 Ð 8.3 6 2.4
B6 Ly5.1 and B6 I-Aa2/2 4.2 6 0.6 3.9 6 1.2 22.7 6 2.9 5.4 6 2.1
a Spleen of chimeric mice were analyzed by FACS after triple labeling with Cy5-conjugated anti-B220 (clone RA3-6B2, Pharmingen), biotinylated
mAb493 (anti-pB130-140), and FITC-conjugated anti-Ly5.1 (clone A20, Pharmingen) or FITC-conjugated anti-Ly5.2 (clone 104, Pharmingen).
The biotinylated mAb was revealed with PE-conjugated streptavidin (Southern Biotechnology). Immature B cells are defined as B2201/pB130-
1401 while mature B cells are B2201/pB130-1402. The percentages represent the mean 6 SD of at least three individual mice analyzed.
Values in bold represent significant differences compared to wild-type control mice.
The immature bone marrow and splenic B cell com- A Defective btk Gene Dramatically Reduces
the Efficiency of Immature Splenic B Cellspartments of the B6 mice reconstituted with the mixture
containing 2.5 3 106 normal B6 Ly5.1 and 2.5 3 106 B6 to Differentiate into Mature B Cells
Previous studies have shown that mice carrying a defec-I-Aa2/2 bone marrow cells consisted of about 50% B6
Ly5.1 and 50% B6 I-Aa2/2-derived cells (data not shown; tive btk gene have a severely reduced mature B cell
compartment (Hardy et al., 1983; Khan et al., 1995, 1997;Table 3). Thus, even under competitive conditions, B6
I-Aa2/2 B cell development is normal up to and including Oka et al., 1996; Klaus et al., 1997; see also Table 1).
However, as also shown previously, B cell developmentthe immature splenic B cell compartment. However, the
B6 Ly5.1-derived mature splenic B cell compartment is up to and including immature B cells in the bone marrow
is not affected (Oka et al., 1996). Moreover, as shownabout 4-fold the size of that derived from the B6 I-Aa2/2
bone marrow in these mixed chimeras. In conclusion, in Table 1, the number of immature splenic B cells is
normal, while the number of mature B cells in the spleenthe B cell maturation defect of the B6 I-Aa2/2 mouse
cannot be rescued by MHC class II±expressing hemato- is 4- to 5-fold reduced in btk mutant CBA/N mice. To
determine whether this reduction is due to a shorterpoetic cells and therefore is most likely due to an intrinsic
B cell defect. half-life time of the mature B cells or to a decreased
efficiency of immature splenic B cells to differentiateSince the Bcl-2 protein is a critical determinant of
lymphocyte lifespan, we tested whether there are mea- into the mature compartment, BrdU labeling and chase
experiments were performed. Similar to all other mousesurable differences in the level of Bcl-2 expression in
splenic B cells from B6 I-Aa2/2 compared to wild-type strains tested, over 90% of the immature splenic B cells
in CBA/N mice are BrdU positive after 14 days of labelingB6 mice. Using the novel mAb specific for mouse Bcl-2,
we detected no differences in the FACS profiles from (Table 2). Similar to B6 and B6 I-Ab2/2 mice, about 20%
of the mature B cells in CBA/N mice become BrdU posi-permeabilized mature splenic B cells of mutant and wild-
type B6 mice (data not shown). tive after 14 days of labeling (Table 2). Moreover, 2 weeks
after withdrawal of BrdU (chase), 18% of the mature B
cell compartment in CBA/N mice remain BrdU positive,
indicating that the half-life of mature B cells in theseMolecules Known to Interact with MHC Class II
Are Not Involved in the B Cell Maturation mice is comparable to wild-type B6 mice. Thus, the 4- to
5-fold reduction in size of the mature B cell compartmentDefect of B6 I-Aa2/2 Mice
The TCR-CD3 complex as well as CD4 are essential is most likely due to an impaired transition from imma-
ture to mature B cells in the spleen and not, like in themolecules on helper T cells involved in interactions with
MHC class II molecules on antigen-presenting cells, i.e., B6 I-Aa2/2 mice, due to a reduced half-life of mature B
cells.also on B cells. Also, the LAG-3 molecule has been
shown to be able to interact with MHC class II molecules
(Huard et al., 1995). To test whether these interactions Severe Reduction in the Number of Mature B Cells
might play a role in this Aa-dependent B cell maturation, in B6 I-Aa2/2/CBA/N btk-Defective
B cell development was analyzed in CD32/2, CD42/2, Double Mutant Mice
and Lag-32/2 mice. Since the origin of the defect in the mature B cell com-
The results of these analyses presented in Table 1 partment in B6 I-Aa2/2 mice and CBA/N mice was differ-
show that no obvious defects in the transition from im- ent, we tested whether these two defects could act
mature to mature B cells are detectable in the spleen synergistically. Therefore, B6 I-Aa2/2/CBA/N btk-defec-
of these mice. Additionally, like in MHC class II2/2 mice, tive double mutant mice were bred and analyzed.
no defects at other points of B cell development in bone As shown in Table 1 and Figure 3, B6 I-Aa2/2 btk-
marrow are detectable also in these mutant mice (data defective double mutant mice have about half the num-
not shown). Therefore, normal B cell development ap- ber of immature splenic B cells as their single mutant
pears to be independent of the interactions between counterparts. However, mature B cells are practically
MHC class II molecules and the TCR-CD3 complex absent in these miceÐnot only in the spleen (Figure 3)
but also in other lymphoid organs, such as lymph nodesand/or CD4 or LAG-3.
Immunity
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be true for defects in DM or invariant chain synthesis
(Shachar and Flavell, 1996; Kenty et al., 1998). However,
in all likelihood, this cannot be the reason for the short-
ened lifespan of a mature B cell, since B cell maturation
and lifespan is normal in B6 I-Ab2/2 mice. If MHC class
II expression is required, how do B6 I-Ab2/2 mice man-
age? Ruberti et al. described heterodimers of AbdEad
that play an important role in the immune response
against a peptide from sperm whale myoglobin (Ruberti
et al., 1993). Several laboratories have also shown that
AbEa heterodimers can be formed by in vitro transfec-
tion experiments (Anderson and David, 1989; Anderson
et al., 1989; Matsunaga et al., 1990; Mineta et al., 1990).
Hence, the B6 I-Ab2/2 mice might be able to form hetero-Figure 3. Severe B Cell Maturation Defect in B6 I-Aa2/2/CBA/N Dou-
dimers between Aa and Eb, and the expression of theseble Mutant Mice
heterodimers might be the reason for the normal B cellB220/pB130-140 expression on spleen cells from adult CBA/N and
development. However, it must be noted that the exis-B6 I-Aa2/2/CBA/N double mutant mice. Spleen cells were labeled
with mAb 493 and an anti-B220 mAb and were analyzed by flow tence of AaEb heterodimers has never been docu-
cytometry. Numbers in quadrants indicate percentage of total gated mented experimentally, and by analyzing cells from the
lymphoid cells. B6 I-Ab2/2 mice we have also not found evidence for
the existence of AaEb heterodimers either. Alternatively,
it might be hypothesized from the experiments pre-and bone marrow (data not shown). The low percentage
sented here that Aa alone can associate with other mole-of splenic B2201 cells that do not express the 493 marker
cules to form a complex involved in B cell maturationare also CD192 (data not shown) and therefore probably
and maintenance either directly, i.e., in contact with ado not belong to the B cell lineage. Thus, the defects
ligand in the environment of bone marrow, or indirectly,of the B6 I-Aa2/2 and btk-defective CBA/N mouse act
by providing structures for such a contact.synergistically, resulting in the complete absence of a
Shachar and Flavell (1996) some time ago reportedmature B cell compartment. Immunohistochemical anal-
that mice lacking the invariant chain (Ii) associated withysis of spleen cryosections showed the presence of B
MHC class II molecules have an impaired B cell matura-cell follicles in the CBA/N and B6 I-Aa2/2 single mutant
tion. Based on the findings that B cell development inmice (Figure 4). In marked contrast, the B6 I-Aa2/2/btk-
B6 I-Ab2/2 mice is normal and that irradiated wild-typedefective double mutant mice have no proper B cell
mice reconstituted with bone marrow from Ii2/2 micefollicles. Instead, their B cells are scattered loosely
still showed the defect, the authors concluded that thearound the T cell areas and throughout the red pulp.
block in the Ii2/2 mice is an intrinsic feature of B cells
that is independent of MHC class II expression. MoreDiscussion
recently, Kenty et al. (1998) analyzing mice lacking the
nonconventional MHC class II product DM also ob-
Recently, we have described a mAb, called 493, that
served a B cell maturation defect, and interestingly,
enabled us to distinguish immature from mature B cells found an even more severe defect in Ii2/2DM2/2 double
(Rolink et al., 1998). Here, we have used this novel mAb mutant mice. Thus, these two studies also, like ours
to analyze B cell development in mice deficient in MHC presented herein, point at an important role for MHC
class II expression. class II molecules in B cell maturation.
Our analyses confirm those of others (Cosgrove et al., Like B6 I-Ab2/2 mice, mice lacking the MHC class II
1991; Grusby et al., 1991; Markowitz et al., 1993) that B transactivator (CIITA) have an impaired MHC class II
cell development in B6 I-Ab2/2 mice is unaffected. Thus, expression. They do not show an obvious B cell matura-
the sizes of the precursor, immature, and mature B cell tion defect (Chang et al., 1996). However, the Ii and DM
compartments as well as the lifespan of these cells in genes are still expressed in CIITA2/2 mice, although at
B6 I-Ab2/2 mice are indistinguishable from those found about 10-fold reduced steady state levels. Moreover,
in wild-type B6 mice. In B6 I-Aa2/2 mice, the size and very low but significant amounts of I-Aa transcripts were
turnover of the precursor and immature B cell compart- also detectable in these mice (Chang et al., 1996). Thus,
ments are also comparable to wild-type B6 mice. How- the possibility that CIITA2/2 mice produce low amounts
ever, we find a 4- to 5-fold reduced number of mature of MHC class II protein, especially I-Aa, might explain
B cells in B6 I-Aa2/2 mice. BrdU labeling and chase the absence of an obvious B cell maturation defect in
experiments indicate that a severe reduction in the life- these mice.
span of mature B cells in B6 I-Aa2/2 mice (4 weeks In this paper, we show that an Ead transgene that
versus 15±20 weeks in B6 and B6 I-Ab2/2 mice) is the gives rise to MHC class II expression on precursor and
direct cause of this smaller peripheral compartment. immature B cells can rescue B cell maturation in B6
The obvious question arising from our analyses is why I-Aa2/2 mice, while an Ead transgene that is expressed
the lifespan of a mature B cell is shortened when MHC only on mature B cells cannot. This makes us favor the
class II I-Aa chains are not synthesized early in B cell idea that MHC class II expression on precursors and/or
development. One possible reason could be a conges- immature B cells is required for optimal B cell maturation.
tion of the endoplasmic reticulum with improperly as- Indeed, the early expression of the EAD-J transgene on
precursor B cells in the bone marrow of B6 I-Aa2/2 micesembled MHC class II molecules, and this would also
Regulation of the Mature B Cell Pool Size
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Figure 4. B6 I-Aa2/2/CBA/N Double Mutant
Mice Lack B Cell Follicles
Cryosections from (A) B6 I-Aa2/2, (B) CBA/N,
and (C). B6 I-Aa2/2/CBA/N mice were incu-
bated with Texas red±conjugated goat anti-
mouse IgM (red) and rat anti-Thy 1 (T24) fol-
lowed by mouse anti-rat IgG conjugated to
FITC (green). While the single mutant mice
show development of B cell zones (red)
around the T cell containing PALS (green),
these structures are absent or drastically re-
duced in the double mutant (C).
(Figure 2) resembles that of wild-type MHC class II ex- tion-defective B6 I-Aa2/2 mice carrying the EAD-107
transgene (Brocker et al., 1997). We, therefore, favor thepression found in normal mice (Tarlinton, 1993).
Positive selection of CD4 T cellsÐa process depen- idea that MHC class II expression on precursors and/or
immature B cells, and not on another cell type, is re-dent on the expression of MHC class II molecules on
thymic epithelial cellsÐis normal in the B cell matura- quired for optimal B cell maturation. This conclusion is
Immunity
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strongly supported by the finding that the B6 I-Aa2/2 B differentiate into the mature compartment. Since in bcl-2
cell maturation defect is still prominent in the environ- transgenic CBA/N mice a complete normalization of the
ment of an irradiated wild-type B6 mouse reconstituted mature B cell compartment with respect to numbers is
with either B6 I-Aa2/2 bone marrow alone or with a observed (Woodland et al., 1996), the half-life time of
mixture of wild-type and B6 I-Aa2/2 bone marrow. the immature splenic B cells in these mice might form
The results of this paper indicate that MHC class II the basis for this defect. Thus, by virtue of the novel
expression, or at least I-Aa chain expression, is not mAb 493, we have now defined two different mutant
needed for the generation of normal numbers of imma- mice, B6 I-Aa2/2 and CBA/N, which both have a severely
ture B cells in bone marrow (expressing MHC class II reduced mature B cell compartment. The two mutants
molecules) nor for their transit to mature B cells. How- differ however in that B6 I-Aa2/2 mice show normal input
ever, it is mandatory for mature B cells to obtain a long but decreased maintenance of mature B cells, whereas
lifespan in the periphery. The mechanism by which MHC CBA/N mice display decreased input but normal mainte-
class II participates in this B cell maturation process is nance of the mature B cell pool. Consequently, btk-
unknown. Either MHC class II expression by itself on defective B6 I-Aa2/2 double mutant mice are devoid of
immature B cells without interaction with a ligand is mature B cells. In conclusion, the size of the mature B
sufficient and necessary, or a binding of a ligand, maybe cell pool in spleen is controlled by reactions affecting
on other cells, is needed. The three molecules known the rate of production or the lifespan of the cells. When
to interact with MHC class II, namely the TCR-CD3 com- mutations that reduce either of the two are combined,
plex, CD4, and LAG-3, do not appear to be involved a severe mature B cell deficiency results that can be
(Table 1). Thus, another, yet unknown, molecule capable seen in many peripheral lymphoid organs.
of interacting with MHC class II might be involved, and
this molecule might either be expressed on immature B Experimental Procedures
cells or on cooperating cells that are not the classical
MiceCD41 helper T cells.
C57BL/6 (herein called B6) mice and the btk mutant CBA/N miceMembers of the Bcl-2 family of protooncogenes play
were purchased from Biological Research Laboratories (FuÈ llinsdorf,a major role in regulating cellular responses to apoptotic
Switzerland). CD3e2/2 (Malissen et al., 1995) and B6 I-Ab2/2 (Cos-
signals, and the Bcl-2 protein is a critical determinant grove et al., 1991) mice were originally obtained from the CNRS
of lymphocyte lifespan (Veis et al., 1993; Newton and animal facility (CNRS/CDTA, Orleans, France). Mice deficient for
Strasser, 1998). A possible reason for decreased life- LAG-3 (Lag-32/2; Miyazaki et al., 1996) were kindly given to us by
Dr. Petter HoÈ glund, IGBMC, Universite Louis Pasteur, Strasbourg,span of mature B cells in MHC class II I-Aa2/2 mice
France. B6 I-Aa2/2 (Kontgen et al., 1993) mice were originally madecould be decreased levels of Bcl-2 protein expression
at Basel Institute for Immunology, while the B6 Ead transgenic 107.1(Lu et al., 1999). However, after cytoplasmic immunoflu-
line (herein called EAD-107) (Widera et al., 1987) was kindly given
orescent staining and FACS analyses we could not de- to us by Dr. R. Flavell, Yale University. The B6 Ead transgenic line
tect any differences in the level of Bcl-2 expression (herein called EAD-J) originally described by Yamamura et al. (1985)
between either immature or mature splenic B cells of was given to us by Dr. S. Kashiwamura, Osaka University, Osaka,
Japan. CD42/2 (Rahemtulla et al., 1991) and B6 Ly5.1 mice weremutant or wild-type mice.
purchased from Jackson Laboratories. All mutant and transgenicMaintenance and survival of both naive and memory
mice as well as the intercrosses between these were bred underT cells critically depend on interactions between TCR
pathogen-free conditions at the Basel Institute for Immunology.and its MHC ligand (Tanchot et al., 1997). Mature B
cell maintenance and survival is dependent upon BcR Production of BM Chimeric Mice
expression (Lam et al., 1997). Also, the maintenance of B6 mice were irradiated with 950 rad and 4±6 hr later injected with
B cell memory requires presence of antigen, indicating 5 3 106 BM cells. Chimeric mice were analyzed by FACS after 10
weeks of reconstitution.a role for BCR ligand interaction in this process (Mac-
Lennan and Gray, 1986). However, since the defect de-
BrdU Labeling of Cellsscribed herein occurs after the expression of Ig and
BrdU labeling of cells in vivo and determination of BrdU-positivetherefore, most likely, does not influence the B cell re-
cells was performed as previously described (Rolink et al., 1998).
ceptor specificities, it is unlikely that the decreased life-
span is due to a BCR ligand interaction. Antibodies, Flow Cytometric Analysis,
While the effects of defects in the normal maintenance and Cell Sorting
Cell surface labeling was performed as described in Rolink et al.of longevity of mature B cells are visible in MHC class
(1996, 1998), and the labeled cells were analyzed by FACScan orII I-Aa2/2 mice, defects in the rate of production of ma-
FACS Calibur (Becton Dickinson). Determination of bcl-2 content ofture B cells can be seen in btk-defective CBA/N mice.
splenic B cells was done using the FITC-conjugated Bcl-2 AntibodyThis mouse strain shows a wide array of immune de-
Reagent Set (Pharmingen). For sorting of labeled cells, the MoFlo
fects. These include a failure to make antibody re- (Cytomation) or the FACStar PLUS (Becton Dickinson) was used.
sponses to type 2 T-independent antigens (Scher,
1982b) and the absence of B-1 cells (Scher, 1982a; Immunohistology
Hardy et al., 1983). Moreover, while B cell development Spleens from nonimmune CBA/N, B6 I-Aa2/2, and B6 I-Aa2/2/CBA/N
mice were embedded in Tissue-Tek (Sakura Finetek U. S. A.) andin bone marrow is little affected (Khan et al., 1995; Oka
frozen on dry ice. Seven millimeter thick cryosections were fixed inet al., 1996) and immature B cell numbers in spleen
acetone for 10 min and sequentially incubated in rat anti-mouseare relatively normal, CBA/N mice have previously been
Thy-1 (clone T24), mouse anti-rat IgG (H 1 L chain-specific) F(ab9)2analyzed and found to have a severely reduced mature conjugated to FITC (Jackson Immunoresearch Labs) and Texas red±
B cell compartment (Oka et al., 1996; Klaus et al., 1997). conjugated goat anti-mouse IgM (Southern Biotechnology Associ-
Here, we indicate that this defect is due to the decreased ates). After washing in PBS and mounting, the sections were photo-
graphed using a Zeiss Axiophot epifluorescence microscope.frequency by which CBA/N immature splenic B cells
Regulation of the Mature B Cell Pool Size
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